Home » Topics » Regulatory » EMA

EMA
RSS

CHMP grants positive opinion for Truxima

Dec. 20, 2016

EMA validates Sarepta's MAA for eteplirsen in Duchenne muscular dystrophy

Dec. 20, 2016

CHMP grants positive opinion for Alecensa for the treatment of NSCLC

Dec. 20, 2016

CHMP grants positive opinion to acknowledge that Jardiance reduces the risk of CV death

Dec. 20, 2016

Merck & Co.'s Keytruda gets positive opinion from EMA's CHMP

Dec. 19, 2016

EMA committee recommends approval of baricitinib for RA

Dec. 19, 2016

Novartis' Votubia receives positive opinion in E.U.

Dec. 19, 2016

EMA's CHMP backs approval of canakinumab in periodic fever syndromes

Dec. 19, 2016

Gedeon Richter withdraws European applications for biosimilar pegfilgrastim

Dec. 19, 2016

Minoryx Therapeutics' lead candidate granted orphan drug designation in Europe

Dec. 19, 2016

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...